Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Biophore India Pharmaceuticals Pvt Ltd

02 14Bayer AG

03 12care4

04 1ANDA Repository

05 1Amphastar Pharmaceuticals

06 1Annora Pharma

07 7Bracco

08 2Farmak JSC

09 8GE Healthcare Inc

10 2Grupo Juste

11 1Iberoinvesa Pharma Sl

12 5Mallinckrodt Pharmaceuticals

13 1Xian Libang Pharmaceutical Co.,Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Diatrizoate Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 76%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

02

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : ANGIOVIST 370

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-09-23

Application Number : 87723

Regulatory Info : DISCN

Registration Country : USA

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Diatrizoate Sodium; Diatrizoate Meglumine

Brand Name :

Dosage Form : Injection

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

04

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : ANGIOVIST 292

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 52%;8%

Packaging :

Approval Date : 1982-09-23

Application Number : 87724

Regulatory Info : DISCN

Registration Country : USA

Company Banner

05

DIATRIZOATE SODIUM

Brand Name : UROVIST SODIUM 300

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50%

Packaging :

Approval Date : 1982-09-23

Application Number : 87725

Regulatory Info : DISCN

Registration Country : USA

Company Banner

06

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : GASTROVIST

Dosage Form : SOLUTION;ORAL, RECTAL

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-09-23

Application Number : 87728

Regulatory Info : DISCN

Registration Country : USA

Company Banner

07

Sodium amidotrizoate; Megluminamidotrizoate

Brand Name : Gastrografin

Dosage Form : Oral/Rectal Solution

Dosage Strength : 0.1g/ml; 0.66g/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

Company Banner

08

Sodium Amidotrizoate; Meglumine Amidotrizoate

Brand Name : Gastrografin

Dosage Form : Oral And Rectal Solution

Dosage Strength : 370MG

Packaging :

Approval Date : 01-06-1961

Application Number : 36270

Regulatory Info : Authorized

Registration Country : Spain

Company Banner

09

Sodium Amidotrizoate; Meglumine Amidotrizoate

Brand Name : Urografin

Dosage Form : Solution For Injection And Infusion

Dosage Strength : 370MG

Packaging :

Approval Date : 01-06-1955

Application Number : 23817

Regulatory Info : Authorized

Registration Country : Spain

Company Banner

10

Sodium Amidotrizoate

Brand Name : Gastrografin

Dosage Form : LIQ

Dosage Strength : 100mg/1ml

Packaging : 100X1mg/1ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

11

Sodium Amidotrizoate

Brand Name : Urografin 60%

Dosage Form : AMP

Dosage Strength : 1g

Packaging : 20X10g/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

12

Sodium amidotrizoate

Brand Name : Urografin 60%

Dosage Form : AMP

Dosage Strength : 1g

Packaging : 20X10g/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

13

Sodium Amidotrizoate

Brand Name : Urografin 76%

Dosage Form : AMP

Dosage Strength : 2g/ml

Packaging : 20X10g/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

14

Sodium amidotrizoate

Brand Name : Urografin 76%

Dosage Form : AMP

Dosage Strength : 2g/ml

Packaging : 20X10g/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

15

Sodium Amidotrizoate

Brand Name : Urografin 30%

Dosage Form : LIQ

Dosage Strength : 2g/ml

Packaging : 250X1g/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

16

Sodium amidotrizoate

Brand Name : Urografin 30%

Dosage Form : LIQ

Dosage Strength : 2g/ml

Packaging : 250X1g/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Company Banner

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Brand Name : RENOGRAFIN-76

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 66%;10%

Packaging :

Approval Date : 1982-01-01

Application Number : 10040

Regulatory Info : DISCN

Registration Country : USA

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 50%

Packaging :

Approval Date : 1982-01-01

Application Number : 9561

Regulatory Info : DISCN

Registration Country : USA

blank

19

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE SODIUM 20%

Dosage Form : SOLUTION;URETERAL

Dosage Strength : 20%

Packaging :

Approval Date : 1982-01-01

Application Number : 9561

Regulatory Info : DISCN

Registration Country : USA

blank

20

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

DIATRIZOATE SODIUM

Brand Name : HYPAQUE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 25%

Packaging :

Approval Date : 1982-01-01

Application Number : 9561

Regulatory Info : DISCN

Registration Country : USA

blank